Crispr Infuses First Human in Landmark Gene-Editing Study

Crispr Therapeutics and partner Vertex Pharmaceuticals said on Monday morning that the first patient in a trial using CTX001 received the one-time medicine.

from NDTV Gadgets - Latest https://ift.tt/2XjoJ5n

Comments

Popular posts from this blog

Snapchat Rolls Out My AI Chatbot Globally; Announces New Features, AR Tools at Snap Partner Summit 2023

Sony Xperia 1 V Launch Date Set for May 11: Expected Specifications, Features

F1 TV Pro Subscription Now Available in India: Price, Features, and More